National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

erbB kinase inhibitor AZD8931
An erbB receptor tyrosine kinase inhibitor with potential antineoplastic activity. erbB kinase inhibitor AZD8931 binds to and inhibits erbB tyrosine receptor kinases, which may result in the inhibition of cellular proliferation and angiogenesis in tumors expressing erbB. The erbB protein family, also called the epidermal growth factor receptor (EGFR) family, plays major roles in tumor cell proliferation and tumor vascularization. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:AZD8931



Previous:epratuzumab, Eprex, erastin analogue PRLX 93936, Eraxis, erb-38 immunotoxin
Next:ErbB-2 inhibitor ARRY-380, Erbitux, Ergamisol, eribulin mesylate, erlotinib hydrochloride

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov